MYELOPROLIFERATIVE NEOPLASIA MPN EXTENDED PROFILE Test
Test Cost: AED 2810.0
Symptoms and Diagnosis:
The MYELOPROLIFERATIVE NEOPLASIA (MPN) EXTENDED PROFILE test is a comprehensive diagnostic tool used to evaluate and monitor patients with suspected or confirmed myeloproliferative neoplasms (MPNs). MPNs are a group of rare blood disorders characterized by the overproduction of blood cells in the bone marrow.
The MPN EXTENDED PROFILE test includes the following components:
- Complete Blood Count (CBC): This test measures the levels of red blood cells, white blood cells, and platelets in the blood. Abnormalities in these cell counts can indicate the presence of an MPN.
- Bone Marrow Aspiration and Biopsy: This procedure involves the extraction of a small sample of bone marrow tissue for microscopic examination. It helps determine the presence of abnormal cells and assess the overall health of the bone marrow.
- JAK2 V617F Mutation Analysis: The JAK2 gene mutation is commonly associated with MPNs, particularly polycythemia vera (PV) and essential thrombocythemia (ET). This test detects the presence of the JAK2 V617F mutation in the patient’s blood or bone marrow sample.
- CALR Mutation Analysis: CALR gene mutations are also frequently found in MPNs, particularly essential thrombocythemia (ET) and primary myelofibrosis (PMF). This test identifies the presence of CALR mutations in the patient’s blood or bone marrow sample.
- MPL Mutation Analysis: MPL gene mutations are less common but can be present in some MPN cases, particularly primary myelofibrosis (PMF). This test detects the presence of MPL mutations in the patient’s blood or bone marrow sample.
- Additional Molecular Testing: Depending on the specific MPN suspected, additional molecular tests may be included to identify other gene mutations associated with MPNs, such as ASXL1, TET2, or IDH1/2 mutations.
The results of the MPN EXTENDED PROFILE test help healthcare providers establish a definitive diagnosis, classify the specific MPN subtype, and guide treatment decisions. Regular monitoring of these markers can also help assess disease progression and response to therapy.
Test Details:
Sample Condition: 8 mL (4 mL min.) whole blood in 2 Lavender top (EDTA) tubes. Ship refrigerated. DO NOT FREEZE. Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.
Report Delivery: SampleMon by 9 am; Report Sat
Method: Real Time PCR, Sequencing
Test Type: Cancer
Doctor: Hematologist, Oncologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information: Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.
For more information or to schedule an appointment, please contact DNA Labs UAE.
Test Name | MYELOPROLIFERATIVE NEOPLASIA MPN EXTENDED PROFILE Test |
---|---|
Components | *Jak2 V617F*Jak2 Exon 12*BCR-ABL PCR Qualitative*CALR*MPL |
Price | 2810.0 AED |
Sample Condition | 8 mL (4 mL min.) whole blood in 2 Lavender top (EDTA) tubes. Ship refrigerated. DO NOT FREEZE. Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory. |
Report Delivery | SampleMon by 9 am; Report Sat |
Method | Real Time PCR, Sequencing |
Test type | Cancer |
Doctor | Hematologist, Oncologist |
Test Department: | MOLECULAR DIAGNOSTICS |
Pre Test Information | Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory. |
Test Details | The MYELOPROLIFERATIVE NEOPLASIA (MPN) EXTENDED PROFILE test is a comprehensive diagnostic tool used to evaluate and monitor patients with suspected or confirmed myeloproliferative neoplasms (MPNs). MPNs are a group of rare blood disorders characterized by the overproduction of blood cells in the bone marrow. The MPN EXTENDED PROFILE test includes the following components: 1. Complete Blood Count (CBC): This test measures the levels of red blood cells, white blood cells, and platelets in the blood. Abnormalities in these cell counts can indicate the presence of an MPN. 2. Bone Marrow Aspiration and Biopsy: This procedure involves the extraction of a small sample of bone marrow tissue for microscopic examination. It helps determine the presence of abnormal cells and assess the overall health of the bone marrow. 3. JAK2 V617F Mutation Analysis: The JAK2 gene mutation is commonly associated with MPNs, particularly polycythemia vera (PV) and essential thrombocythemia (ET). This test detects the presence of the JAK2 V617F mutation in the patient’s blood or bone marrow sample. 4. CALR Mutation Analysis: CALR gene mutations are also frequently found in MPNs, particularly essential thrombocythemia (ET) and primary myelofibrosis (PMF). This test identifies the presence of CALR mutations in the patient’s blood or bone marrow sample. 5. MPL Mutation Analysis: MPL gene mutations are less common but can be present in some MPN cases, particularly primary myelofibrosis (PMF). This test detects the presence of MPL mutations in the patient’s blood or bone marrow sample. 6. Additional Molecular Testing: Depending on the specific MPN suspected, additional molecular tests may be included to identify other gene mutations associated with MPNs, such as ASXL1, TET2, or IDH1/2 mutations. The results of the MPN EXTENDED PROFILE test help healthcare providers establish a definitive diagnosis, classify the specific MPN subtype, and guide treatment decisions. Regular monitoring of these markers can also help assess disease progression and response to therapy. |